Last reviewed · How we verify

NCT04397250

High-intensity Interval Training for Cardiometabolic Health in Persons With Spinal Cord Injury

Status unknown NA Last updated 29 July 2022
What this trial tests

NA trial testing High-intensity interval training in Paraplegia in 32 participants. Status unknown.

Timeline
1 October 2020
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorUniversity of Bath
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment32
Start date1 October 2020
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Bath

Who can join

Adults 18 to 65, any sex, with Paraplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Persons with chronic paraplegia at an increased risk of developing cardiovascular disease and type-2 diabetes compared to the able-bodied population. There is mounting evidence from the able-bodied literature that high-intensity interval training (HIIT) is an effective way to improve cardiometabolic health outcomes, but this effect has yet to be investigated in persons with chronic paraplegia. This study is recruiting adults (aged 18-65 years) with paraplegia (T2 or below) who sustained their spinal cord injury more than one-year ago. Participants will need to attend the laboratory at the University of Bath on two occasions (baseline and follow-up testing) separated by eight weeks. Following the first visit, participants will be randomised to a exercise group or control group. For those in the exercise group, participants will be provided with an arm crank ergometer for use in their home, and be asked to perform four exercise sessions per week (30 min each) for six weeks. For those in the control group, participants will be asked to continue their normal lifestyle.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Results of a randomized controlled trial.
    Farrow M, Maher J, Deere R, Spellanzon B, et al · · 2024 · cited 8× · PMID 38924175 · DOI 10.1113/ep091803
  2. Effect of high-intensity interval training on cardiometabolic component risks in persons with paraplegia: Protocol for a randomized controlled trial.
    Farrow MT, Maher J, Thompson D, Bilzon JLJ. · · 2021 · cited 7× · PMID 33600014 · DOI 10.1113/ep089110
  3. Virtual Strategies for the Broad Delivery of High Intensity Exercise in Persons With Spinal Cord Injury: Ongoing Studies and Considerations for Implementation.
    McMillan DW, Astorino TA, Correa MA, Nash MS, et al · · 2021 · cited 4× · PMID 34423292 · DOI 10.3389/fspor.2021.703816

Verify or expand the search:

Other trials of High-intensity interval training

Trials testing the same drug.

Other recruiting trials for Paraplegia

Currently open trials in the same condition.

Other University of Bath trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing